<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03566628</url>
  </required_header>
  <id_info>
    <org_study_id>UV-002</org_study_id>
    <nct_id>NCT03566628</nct_id>
  </id_info>
  <brief_title>Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography</brief_title>
  <acronym>SHIVERS</acronym>
  <official_title>Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography: A Randomised Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Valparaiso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Carlos van Buren Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Valparaiso</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether the use of warmed solutions during cerebral angiography reduces
      the incidence of post-anaesthetic shivering. Half of participants will receive pre-warmed
      (39ºC) isotonic saline, while the other half receives the same solution at room temperature.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Shivering is a physiologic reaction aimed at raising body temperature that is very common
      amongst patients undergoing cerebral angiographies. The use of pre-warmed solutions during
      the procedure may reduce the incidence of shivering amongst these patients. In this
      triple-blind randomised trial, a consecutive sample of participants receiving total
      intravenous anaesthesia (TIVA) and undergoing cerebral angiography will be allocated to
      receive a warmed (39ºC) solution of up to 500cc of isotonic saline or the same solution, but
      at room temperature. Patients requiring sedation, those expected to require mechanical
      ventilation after the procedure, those with diminished consciousness (Glasgow Coma Scale &lt;15
      pts) and patients not wishing to participate will be excluded from the study. The primary
      endpoint for this study is the incidence of shivering up to 60 minutes after the procedure is
      completed. Shivering will be assessed using a validated scale by operators unaware of
      treament allocation. All analyses will be undertaken by a statistician that will not
      participate of the clinical assessment of included patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2019</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprocedural Shivering</measure>
    <time_frame>up to 60 minutes</time_frame>
    <description>Once the procedure is completed, the patient will be extubated and the presence or absence of shivering will be recorded up to 60 minutes after the extubation with the Badjatia 2008 scale consisting of a gradual evaluation of 0 to 3 points. With scores greater or equal to 1, shivering is considered established.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Shivering severity</measure>
    <time_frame>60 minutes</time_frame>
    <description>The post operative shivering scale of Badjatia 2008 will be used. It consist of a gradual evaluation of 0 to 3 points, with 0 being the absence of shivering, 1 slight shivering, 2 moderate and 3 severe. The highest score obtained will be recorded within the measurements made every 5 minutes in the first 60 minutes after extubation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cerebral Angiography</condition>
  <condition>Shivering</condition>
  <arm_group>
    <arm_group_label>Warmed Saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients allocated to this arm will receive a warmed (39ºC) solution of up to 500mL of isotonic saline. This solution will be administered directly to the cerebral vasculature as part of the angiography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room-Temperature Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients allocated to this arm will receive isotonic saline at room temperature. This solution will be administered directly to the cerebral vasculature as part of the angiography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Warmed Isotonic Saline</intervention_name>
    <description>Isotonic saline warmed to 39ºC.</description>
    <arm_group_label>Warmed Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Room-Temperature Isotonic Saline</intervention_name>
    <description>Isotonic saline at room temperature</description>
    <arm_group_label>Room-Temperature Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients receiving TIVA

          -  Patients undergoing cerebral angiography

        Exclusion Criteria:

          -  Glasgow Coma Scale &lt;15 points prior to procedure

          -  Expected need of mechanical ventilation after procedure completion

          -  Use of sedatives

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie Lopez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Carlos Van Buren</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alvaro Silva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Valparaiso</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Martinez, M.D; M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Andrés Bello</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathalie Lopez, MD</last_name>
    <phone>2364000</phone>
    <email>nathalielopez.jq@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Felipe Martinez, M.D; M.Sc.</last_name>
    <phone>2573322</phone>
    <email>f.martinez.lomakin@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Carlos Van Buren</name>
      <address>
        <city>Valparaiso</city>
        <zip>2341131</zip>
        <country>Chile</country>
      </address>
    </facility>
    <contact>
      <last_name>Nathalie Lopez, M.D.</last_name>
      <phone>2364000</phone>
      <email>nathalielopez.jq@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alvaro Silva, M.D.</last_name>
      <phone>2364000</phone>
      <email>alvarosilvariquelme@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>May 27, 2018</study_first_submitted>
  <study_first_submitted_qc>June 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <last_update_submitted>January 28, 2019</last_update_submitted>
  <last_update_submitted_qc>January 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Valparaiso</investigator_affiliation>
    <investigator_full_name>Nathalie Lopez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cerebral Angiography</keyword>
  <keyword>Shivering</keyword>
  <keyword>Anaesthesia</keyword>
  <keyword>Warmed solutions</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

